国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2013年
24期
1900-1905
,共6页
肺动脉高压%前列环素类似物%一氧化氮%磷酸二酯酶抑制剂%Rho激酶抑制剂%血管活性肠肽%肾上腺髓质素%吸入治疗
肺動脈高壓%前列環素類似物%一氧化氮%燐痠二酯酶抑製劑%Rho激酶抑製劑%血管活性腸肽%腎上腺髓質素%吸入治療
폐동맥고압%전렬배소유사물%일양화담%린산이지매억제제%Rho격매억제제%혈관활성장태%신상선수질소%흡입치료
Pulmonary hypertention%Prostacyclin analogues%Nitric oxide%Phosphodiesterase inhibitors%Rho kinase inhibitors%Vasoactive intestinal peptide%Adrenomedullin%Inhalation therapy
肺动脉高压是一种严重的疾病,传统给药途径在治疗的同时,存在体循环血压下降、生物利用度不高等缺点,而一些药物通过呼吸道吸入给药能避免上述不足.本文就近年来有关吸入药物在治疗肺动脉高压的研究进展作一综述.
肺動脈高壓是一種嚴重的疾病,傳統給藥途徑在治療的同時,存在體循環血壓下降、生物利用度不高等缺點,而一些藥物通過呼吸道吸入給藥能避免上述不足.本文就近年來有關吸入藥物在治療肺動脈高壓的研究進展作一綜述.
폐동맥고압시일충엄중적질병,전통급약도경재치료적동시,존재체순배혈압하강、생물이용도불고등결점,이일사약물통과호흡도흡입급약능피면상술불족.본문취근년래유관흡입약물재치료폐동맥고압적연구진전작일종술.
Pulmonary hypertention is a severe disease.The traditional route of administration is widely used in the treatment of pulmonary hypertention,which has some shortcomings,including the decrease of arterial blood pressure and low bioavailability.However,respiratory inhalation therapy can avoid these shortcomings.This article overviews the application on inhalation therapy in treatment of pulmonary hypertention.
